The FDA has halted clinical testing of an Intellia Therapeutics gene-editing therapy following a report that a patient in a Phase 3 study was hospitalized with liver complications. Intellia said the ...
In a cutting-edge medical experiment, a small group of people who had high cholesterol despite taking conventional drugs to lower it saw significant reductions in two major risk factors for heart ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results